Bright-light exposure and exercise program for cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a six-week program combining bright-light exposure with exercise training for patients diagnosed with lung and esophageal cancer. Participants will be randomly assigned to either the experimental group, which receives the intervention, or an active control group that performs stretching exercises. The study aims to assess improvements in sleep-wake rhythm, physical and mental symptoms, quality of life, and long-term outcomes such as recurrence and survival rates. Data will be collected at multiple time points over a year to evaluate the program's impact.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage.
2. At least 20 years of age.
3. Able to communicate in Mandarin Chinese or Taiwanese.
4. Literate and free from cognitive disabilities.
5. The attending physician agrees to participate in the study.
6. Those who can connect to the Internet with mobile devices such as computers, mobile phones, and tablets, or those whose family members can assist in the operation.
7. Those with Karnofsky Performance Scale (KPS) greater than or equal to 70 points.
8. Those who are hospitalized for lung cancer or esophageal cancer lesion resection.

Exclusion Criteria:

1. Congestive heart failure.
2. Orthopedic diseases of the lower extremities that limit one's walking ability.

Where it's running

• Taipei Veterans General Hospital
  Taipei City, Taipei, Taiwan Recruiting
• Taipei Medical University Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: Hui-Mei Chen, PhD — National Taipei University of Nursing and Health Sciences
• Study coordinator: Hui-Mei Chen, PhD
• Email: alice@ntunhs.edu.tw
• Phone: 886-2-28227101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A new treatment model for elderly lung cancer patients

  This trial tests a comprehensive, integrated care approach for older adults with lung cancer to improve perioperative management and outcomes.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07632664

• Proximal versus total gastrectomy for locally advanced Siewert type II–III gastroesophageal junction cancer

  This will see if keeping part of the stomach (proximal gastrectomy) or removing the whole stomach (total gastrectomy) leads to better 3-year disease-free survival for adults with locally advanced Siewert type II–III gastroesophageal junction cancer.

  Recruiting Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Istanbul, Istanbul · NCT07482566

• Omega-3 supplements with PD-1 therapy for advanced esophageal cancer

  This trial will test whether taking omega-3 fish oil (EPA+DHA) together with PD-1 immunotherapy helps adults with recurrent or metastatic esophageal cancer maintain muscle and have better clinical and patient-reported outcomes than a placebo.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT07272382

• LY4337713 for people with FAP-positive ovarian, breast, pancreatic, colorectal, or esophageal cancers

  This trial tests LY4337713, a FAP-targeted lutetium-177 therapy, in people with advanced cancers that show high levels of fibroblast activation protein (FAP).

  Recruiting at 17 sites Phase 1 Eli Lilly and Company · Newport Beach, California and 29 other locations · NCT07213791

• LY4257496 for GRPR-positive advanced breast, colorectal, prostate, and endometrial cancer (OMNIRAY)

  This Phase 1 test tries LY4257496, with GRPR imaging using LY4257529 and sometimes standard treatments, to see if it is safe and helps people with GRPR-positive advanced breast, colorectal, prostate, or endometrial cancer.

  Recruiting at 15 sites Phase 1 Eli Lilly and Company · Duarte, California and 32 other locations · NCT07114601

• High-sensitivity blood test to detect and monitor multiple cancers

  This study will test a high-sensitivity blood test that looks for tumor DNA to detect and follow several common cancers in adults with those cancers or people having routine health screenings.

  Recruiting Yonsei University · Seoul · NCT07035587

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.